HARMONY BIOSCIENCES HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 362.61 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 258.81K shares, a 41.49% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 103.79K shares, a 236.60% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 35.55K shares, a 64.60% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 34.32K shares, a 41.43% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 283.63K shares, a 51.81% increase from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 186.84K shares, a 12.25% decline from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 212.92K shares, a 0.42% decline from fiscal 2022.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 213.81K shares, a 43.28% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 258.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 362.61K shares 10-Q · filed 2026-08-04 | 398.16K shares derived: sum of 3 quarters · filed 2026-08-04 | 432.48K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 103.79K shares 10-Q · filed 2026-05-07 | 139.34K shares derived: sum of 2 quarters · filed 2026-05-07 | 173.67K shares derived: sum of 3 quarters · filed 2026-05-07 | 356.59K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 35.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 69.88K shares derived: sum of 2 quarters · filed 2026-02-24 | 252.80K shares derived: sum of 3 quarters · filed 2026-02-24 | 283.63K shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 34.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 217.25K shares derived: sum of 2 quarters · filed 2025-11-04 | 248.08K shares 10-Q · filed 2025-11-04 | 348.53K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 182.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 213.76K shares 10-Q · filed 2025-08-05 | 314.20K shares derived: sum of 3 quarters · filed 2025-08-05 | 372.81K shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 30.84K shares 10-Q · filed 2025-05-06 | 131.28K shares derived: sum of 2 quarters · filed 2025-05-06 | 189.88K shares derived: sum of 3 quarters · filed 2025-05-06 | 206.15K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 100.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 159.05K shares derived: sum of 2 quarters · filed 2025-02-25 | 175.31K shares derived: sum of 3 quarters · filed 2025-02-25 | 186.84K shares 10-K · filed 2025-02-25 |
| 2024-09-30 | 58.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | 74.86K shares derived: sum of 2 quarters · filed 2024-10-29 | 86.39K shares 10-Q · filed 2024-10-29 | 93.00K shares derived: sum of 4 quarters · filed 2024-10-29 |
| 2024-06-30 | 16.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 27.79K shares 10-Q · filed 2024-08-06 | 34.40K shares derived: sum of 3 quarters · filed 2024-08-06 | 46.09K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 11.53K shares 10-Q · filed 2024-04-30 | 18.13K shares derived: sum of 2 quarters · filed 2024-04-30 | 29.83K shares derived: sum of 3 quarters · filed 2024-04-30 | 65.65K shares derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-12-31 | 6.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 18.30K shares derived: sum of 2 quarters · filed 2024-02-22 | 54.13K shares derived: sum of 3 quarters · filed 2024-02-22 | 212.92K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 11.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 47.52K shares derived: sum of 2 quarters · filed 2023-10-31 | 206.32K shares 10-Q · filed 2023-10-31 | 251.38K shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 35.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 194.62K shares 10-Q · filed 2023-08-01 | 239.68K shares derived: sum of 3 quarters · filed 2023-08-01 | 321.11K shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2023-03-31 | 158.80K shares 10-Q · filed 2023-05-02 | 203.85K shares derived: sum of 2 quarters · filed 2023-05-02 | 285.28K shares derived: sum of 3 quarters · filed 2023-05-02 | 308.95K shares derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | 45.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | 126.48K shares derived: sum of 2 quarters · filed 2023-02-21 | 150.15K shares derived: sum of 3 quarters · filed 2023-02-21 | 213.81K shares 10-K · filed 2023-02-21 |
| 2022-09-30 | 81.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 105.09K shares derived: sum of 2 quarters · filed 2022-11-01 | 168.76K shares 10-Q · filed 2022-11-01 | 188.10K shares derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | 23.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 87.33K shares 10-Q · filed 2022-08-02 | 106.67K shares derived: sum of 3 quarters · filed 2022-08-02 | 163.01K shares derived: sum of 4 quarters · filed 2022-08-02 |
| 2022-03-31 | 63.66K shares 10-Q · filed 2022-05-03 | 83.00K shares derived: sum of 2 quarters · filed 2022-05-03 | 139.34K shares derived: sum of 3 quarters · filed 2022-05-03 | 384.93K shares derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | 19.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 75.68K shares derived: sum of 2 quarters · filed 2022-02-28 | 321.26K shares derived: sum of 3 quarters · filed 2022-02-28 | 376.95K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 56.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 301.93K shares derived: sum of 2 quarters · filed 2021-11-09 | 357.62K shares 10-Q · filed 2021-11-09 | 370.28K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 245.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 301.28K shares 10-Q · filed 2021-08-10 | 313.94K shares derived: sum of 3 quarters · filed 2021-08-10 | |
| 2021-03-31 | 55.69K shares 10-Q · filed 2021-05-11 | 68.35K shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | 12.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 112.55K shares 10-K · filed 2021-03-25 | ||
| 2020-09-30 | 99.89K shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |